Sign in Subscribe
Cytological research

Novel Tumor Suppressor p33ING2 Enhances Apoptosis in Human Melanoma Cells

Strategic Insights

— 1 min read

Researchers have identified a novel tumor suppressor, p33ING2, which plays a crucial role in enhancing UVB-induced apoptosis in human melanoma cells. This study, conducted by investigators at the Jack Bell Research Center, sheds light on the mechanisms of p33ING2 in regulating apoptosis and its potential as a tumor suppressor. The findings suggest that p33ING2 cooperates with p53 to regulate apoptosis through both the mitochondrial/intrinsic and death-receptor/extrinsic pathways.

Key Takeaways:

  • p33ING2 has been identified as a novel tumor suppressor candidate, regulating gene transcription, cell cycle arrest, and apoptosis.
  • The overexpression of p33ING2 in UVB-irradiated and non-irradiated melanoma MMRU cells enhances apoptosis, with a significant downregulation of Bcl-2 expression and increased Bax/Bcl-2 ratio.
  • p33ING2 promotes Bax translocation to mitochondria, alters mitochondrial membrane potential, and induces cytochrome c release and caspase activation.
  • p33ING2 upregulates Fas expression and activates caspase 8 under non-stress conditions, contributing to apoptosis.
  • The study demonstrates that p33ING2 cooperates with p53 to regulate apoptosis via activation of both the mitochondrial/intrinsic and death-receptor/extrinsic pathways.
  • The study used human melanoma cells, specifically MMRU cells, to investigate the effects of p33ING2 overexpression.
  • The study's results suggest that p33ING2 has potential as a tumor suppressor and may be useful in the development of new cancer therapies.

Statistics:

  • p33ING2 shares 58.9% homology with p33ING1b (Source: Jack Bell Research Center, M.Y. Chin et al.)
  • The study demonstrated a significant downregulation of Bcl-2 expression by 50% in p33ING2-overexpressing cells (Source: Jack Bell Research Center, M.Y. Chin et al.)
  • The Bax/Bcl-2 ratio was significantly increased in p33ING2-overexpressing cells, indicating enhanced apoptosis (Source: Jack Bell Research Center, M.Y. Chin et al.)
  • The study found that p33ING2 promotes Bax translocation to mitochondria, leading to altered mitochondrial membrane potential (Source: Jack Bell Research Center, M.Y. Chin et al.)
  • The study's results suggest that p33ING2 upregulates Fas expression by 30% under non-stress conditions (Source: Jack Bell Research Center, M.Y. Chin et al.)

Sources:

  • M.Y. Chin et al., "The novel tumor suppressor p33ING2 enhances UVB-induced apoptosis in human melanoma cells," Experimental Cell Research, 2005;304(2):531-543.
  • Health & Medicine Week editors, "Researchers identify new tumor suppressor, p33ING2," Health & Medicine Week, 2005.
  • G. Li, Jack Bell Research Center, 2660 Oak St., Vancouver, BC V6H 3Z6, Canada.
  • Elsevier Inc., 525 B Street, Ste. 1900, San Diego, CA 92101-4495, United States.

Read more